Association of functional gene polymorphisms of matrix metalloproteinase (MMP)‐1, MMP‐3 and MMP‐9 with the progression of chronic liver disease
The DOI matches its Crossref record.
Abstract
Background and Aims: Matrix metalloproteinases (MMP) play an important role in the progression of liver fibrosis in addition to fibrogenesis. MMP‐1, MMP‐3, and MMP‐9 gene polymorphisms have been shown to influence the transcriptional activity of their respective gene promoter in an allele‐specific manner. The aim of this study was to examine the possible association of MMP‐1, MMP‐3, and MMP‐9 gene polymorphisms with the progression of chronic liver disease in the Japanese population. Methods: We examined 91 patients with HCV‐related chronic hepatitis and 89 patients with HCV‐related liver cirrhosis. We determined MMP‐1 1G/2G, MMP‐3 5A/6A, and MMP‐9 C/T polymorphisms using polymerase‐chain reaction based assays. Results: In MMP‐1 genotypes, the 2G homozygotes were significantly more in cirrhotic group than in chronic hepatitis group. In MMP‐3 genotypes, there were no significant differences in genotype distributions and allele frequencies between chronic hepatitis and liver cirrhosis groups. However, 5A carriers had a significantly lower age at liver cirrhosis diagnosis and a higher Child–Pugh score compared with the 6A homozygotes. In MMP‐9 genotypes, the C homozygotes and C allele frequencies were significantly more in liver cirrhosis group than in chronic hepatitis group. Conclusion: These findings suggest that MMP‐1, MMP‐3, and MMP‐9 gene polymorphisms account for some of the variability in the progression of HCV‐related chronic liver diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Pathogenesis of non-alcoholic fatty liver disease
Dowman, J. K., Tomlinson, J. W., & Newsome, P. N. (2010) · QJM · doi:10.1093/qjmed/hcp158 · Cited by 741
Matrix metalloproteinases: Evolution, gene regulation and functional analysis in mouse models
Fanjul-Fernández, M., Folgueras, A. R., Cabrera, S., & López-Otín, C. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2009.07.004 · Cited by 582
Hemmann, S., Graf, J., Roderfeld, M., & Roeb, E. (2007) · Journal of Hepatology · doi:10.1016/j.jhep.2007.02.003 · Cited by 509
Non invasive fibrosis biomarkers reduce but not substitute the need for liver biopsy
Sebastiani, G. (2006) · World Journal of Gastroenterology · doi:10.3748/wjg.v12.i23.3682 · Cited by 266
PAI‐1 deficiency reduces liver fibrosis after bile duct ligation in mice through activation of tPA
Wang, H., Zhang, Y., & Heuckeroth, R. O. (2007) · FEBS Letters · doi:10.1016/j.febslet.2007.05.049 · Cited by 98
“have altered expression after hepatic injury and have been hypothesized to influence fibrosis [24–27].”
Background
Metadata
- Authors
- OKAMOTO, K., MIMURA, K., MURAWAKI, Y., & YUASA, I.
- Venue
- Journal of Gastroenterology and Hepatology
- Publisher
- Wiley
- Published
- 2005-06-07
- Volume
- 20
- Issue
- 7
- Pages
- 1102-1108
- ISSN
- 0815-9319 (ISSN-L)
- 1440-1746
- OpenAlex
- W1549842208
- Cited by
- 64
- References
- 0
- FWCI
- 2.76
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Association of functional gene polymorphisms of matrix metalloproteinase (MMP)‐1, MMP‐3 and MMP‐9 with the progression of chronic liver disease. https://app.cochat.ai/papers/10.1111/j.1440-1746.2005.03860.x
- The paper
- OKAMOTO, K., MIMURA, K., MURAWAKI, Y., & YUASA, I. (2005). Association of functional gene polymorphisms of matrix metalloproteinase (MMP)‐1, MMP‐3 and MMP‐9 with the progression of chronic liver disease. Journal of Gastroenterology and Hepatology. https://doi.org/10.1111/j.1440-1746.2005.03860.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.